Alarming Levels of Toxic 'Forever Chemicals' Detected in Blood of North Yorkshire Residents
Exclusive blood testing conducted in the small rural town of Bentham, North Yorkshire, has uncovered alarming levels of toxic per- and polyfluoroalkyl substances (PFAS), commonly known as 'forever chemicals,' in the blood of residents and former factory workers. This discovery follows a previous investigation that revealed Bentham as the site of the highest recorded PFAS contamination in the UK, linked to a local factory that produced firefighting foam containing these persistent chemicals from 1976 to 2024.
Shocking Blood Test Results Expose Health Risks
As part of a new ITV documentary, blood samples were taken from 39 individuals in Bentham, with results showing that nearly a quarter (23%) fall into the highest risk category for adverse health effects. The highest recorded PFAS level was 405 nanograms per milliliter (ng/ml), which is more than 200 times greater than the US risk threshold of 2 ng/ml set by the National Academies of Sciences, Engineering, and Medicine (NASEM). This extreme level was found in a former worker at Angus Fire, the factory implicated in the contamination.
In the United States, NASEM guidelines indicate that blood PFAS levels above 2 ng/ml pose a potential for adverse health effects, while levels exceeding 20 ng/ml warrant increased risk and consideration for more frequent health screenings. In Bentham, many residents, including 34-year-old Stephen Illston with a level of 55 ng/ml, have reported health issues such as infertility, which research links to PFAS exposure. Illston expressed relief at finding a possible cause, stating it provided an answer to years of personal struggle.
Expert Analysis and Community Impact
Dr. David Megson, a forensic environmental scientist and PFAS expert at Manchester Metropolitan University, analyzed the blood results and expressed shock at the findings. He noted that the levels in Bentham are exceptionally high compared to general background populations, with a significant portion of tested individuals exceeding normal expectations. Dr. Shubhi Sharma from the environmental charity Chem Trust emphasized the alarming nature of these levels, given their association with various adverse health outcomes, including certain cancers.
An internal Environment Agency report from 2024 suggested that aerial dispersal from foam testing at the Angus Fire factory could be a likely pathway for community exposure. This could occur through the consumption of locally grown produce, raising concerns about widespread contamination beyond the factory site. Residents like Lindsay Young, who has a PFAS level of 30 ng/ml, described frequent test fires at the factory that released billowing black smoke, adding to local anxieties.
Regulatory Gaps and Corporate Response
In the UK, there are no established guidelines for safe levels of PFAS in blood, creating a regulatory void. Angus Fire responded to the findings by stating that there is no internationally accepted way to interpret PFAS blood tests and limited agreement on the relationship between exposure, blood levels, and health effects. The company argued that classifying the data as 'unusually high' is unfounded in the UK context and noted that the test group was small. They also claimed that historical operations were not the sole source of PFAS in the area and that they have followed regulatory guidelines.
However, experts like Dr. Tony Fletcher, an epidemiologist at the London School of Hygiene and Tropical Medicine, highlighted that high PFAS levels in non-workers suggest community exposure, possibly through environmental pathways. The Environment Agency and North Yorkshire council indicated that fire testing at the site was not regulated under existing permits, with exemptions under the Clean Air Act 1993 further complicating oversight.
Health Interventions and Ongoing Concerns
Dr. Fletcher, who advises the Jersey government on similar PFAS contamination issues, recommended potential interventions for those with elevated levels, such as the use of cholesterol-lowering drugs like colesevelam or bloodletting, to reduce PFAS concentrations. He urged affected individuals in Bentham to discuss these options with healthcare providers.
The documentary, In Our Blood: The Forever Chemicals Scandal, set to broadcast on ITV, aims to shed light on this pressing environmental and health crisis. As the EU moves toward a blanket ban on PFAS, questions remain about the UK's regulatory approach and the long-term health impacts on communities like Bentham.
